Addex Therapeutics (ADXN) Tax Provisions (2023 - 2024)
Addex Therapeutics' (ADXN) quarterly Tax Provisions came in at $0.05 in Q4 2024, up 102.51% year-over-year from $0.02 in Q1 2024, and up 297.8% quarter-over-quarter from -$0.02 in Q3 2024.
Powered by 
Analysis
Addex Therapeutics (ADXN) Tax Provisions (2023 - 2024) Analysis & Trends
Addex Therapeutics has disclosed Tax Provisions across 2 years of filings, most recently posting $0.05 for Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | 1.21 Bn |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | 662.00 Mn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | 654.00 Mn |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | -1.01 Bn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | -407.00 Mn |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | -524.23 Mn |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | - |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | 165.91 Mn |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | 39.70 Mn |
| 10 | Addex Therapeutics | 6.46 Mn | 6.46 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 0.05 |
| Sep 30, 2024 | -0.02 |
| Jun 30, 2024 | -0.01 |
| Dec 31, 2023 | 0.02 |
| Sep 30, 2023 | -0.01 |
| Jun 30, 2023 | -0.01 |